CompletedNot Applicable

The Effect of Solifenacin on Post Void Dribbling in Women

United States118 participantsStarted 2011-11

Plain-language summary

This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.

Who can participate

Age range

18 Years – 89 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Women between the ages of 18 and 89
. Incontinence in the form of post void dribbling that occurs at least twice weekly.

Exclusion criteria

. Severe renal or hepatic disease.
. Active urinary tract infection.
. Glaucoma.
. Stress incontinence as the only incontinence symptom
. Urge incontinence as the only incontinence symptom
. Chronic severe constipation.
. History of bladder cancer.
. Known or suspected hypersensitivity to anticholinergics.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The Percent Reduction in Post Void Dribbling Episodes (Events)

Timeframe: outcome measures will be assessed at week 0 (baseline), and compared to an average measure of weeks 10 through 12

Trial details

NCT IDNCT01470001

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-09

Results submitted2016-09-28

View on ClinicalTrials.gov More Post-micturition Incontinence trials